TOFA analogs useful in treating dermatological disorders or conditions
US9782382B2 · kind B2 · utility
0Cited by
82References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2016 |
| Grant date | Oct 10, 2017 |
| Priority date | — |
| Expiry date | Aug 4, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D407/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to analogs of 5-(tetradecyloxy)-2-furancarboxylic acid (TOFA) and their use in the treatment of dermatological disorders or conditions characterized by sebaceous gland hyperactivity, such as acne and oily skin, and other dermatological disorders and conditions. This invention is also directed to pharmaceutical compositions comprising analogs of TOFA and a pharmaceutically acceptable excipient for dermatological or oral administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.